NCT02260050View on ClinicalTrials.gov

Bioequivalence of the New Formulation of WAL 801 CL Dry Syrup Compared to the Conventional Formulation of WAL 801 CL Dry Syrup in Healthy Male Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

34

Participants

Timeline

Start Date

June 30, 2004

Primary Completion Date

July 31, 2004

Conditions
Healthy
Interventions
DRUG

WAL 801 CL dry syrup new formulation

DRUG

WAL 801 CL dry syrup conventional formulation

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY

NCT02260050 - Bioequivalence of the New Formulation of WAL 801 CL Dry Syrup Compared to the Conventional Formulation of WAL 801 CL Dry Syrup in Healthy Male Volunteers | Biotech Hunter | Biotech Hunter